European Companies Search Engine
Registration · MD: Rainer Kern, Karl Ulrich Kolland · Capital: €25,000 · Shareholder agreement · Seat: Berlin · Legal form: GmbH · Name: Berlin-Chemie Arzneimittel GmbH · Proxy policy … Hrb24 Jul 2007 German Trade Register Announcements, Germany (20/07/2007)
Overview
Text
Berlin-Chemie Arzneimittel GmbH, Berlin (
Unnamed street ??, 12489 Berlin, Germany
). Company: Berlin-Chemie Arzneimittel GmbH; Headquarters: Berlin; The aim is to carry out research and development of medicinal products, to acquire and sell land and accessories, to manage buildings and land in respect of the areas of activity referred to above, and to carry out services in relation to the areas of activity referred to above. Excluded from this are activities subject to authorisation. Share capital: EUR 25,000; Representation regulation: If a managing director is appointed, he shall represent the company alone. If several directors have been appointed, the company is represented jointly by two directors or by a managing director in community with one authorized representative. The power of sole representation may be granted. Managing Director: 1. Dr. Kern, Rainer, *??.??.????, Berlin; Managing Directors: 2. Kolland, Karl Ulrich, *??.??.????, Berlin; Legal form: LLC; Social contract of: April 24, 2007.
This filing was translated from German to English. The filing refers to a past date, and does not necessarily reflect the current state. The latest known state is available on the following page: Berlin-Chemie Arzneimittel GmbH, Berlin, Germany.